Accelerate to discover

Back to filter

Related topics

Vizgen webinar: spatial relationships in Developmental Biology

Vizgen

Nov 21, 2023

MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...

Validation of an orthotopic non-small cell lung cancer mouse model to use in radiotherapy studies

Precision X-Ray

Oct 30, 2023

The use of pre-clinical orthotopic mouse models is essential for the development of novel therapies targeting solid...

Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy

Spectral Instruments Imaging

Oct 20, 2023

To assess tumour growth, mice were imaged using the AMI-HTX bioluminescent imaging system (Spectral Instruments...

IVIM in vivo platform to study efficacy of adoptive and anti-PD- 1- based immunotherapy

IVIM Technology

Oct 18, 2023

Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-
based immunotherapy
...

Nov 28, 2023

Orion spatial biology platform provides new insight for clinical trial designs

RareCyte

Oct 5, 2023

A breakthrough study just published by Dr. Pashtoon Kasi and colleagues (Weill Cornell Medicine) shares the exciting...

Unleash the power of full spectrum cytometry with Cytek cFluor reagents

Cytek Biosciences

Oct 4, 2023

Unleash the power of full spectrum cytometry with Cytek cFluor reagents, obtain the best resolution from your complex...

Bacterial Lipopolysaccharides Exacerbate NHO Development

MOLECUBES

Oct 2, 2023

Micro-computed tomography (μCT) and NHO volume quantification by using Molecubes β-Cube and X-Cube μPET-CT system...

Nov 28, 2023

Webinar: Join us for an In-Depth Look at the Revolutionary Small Animal Radiotherapy System at STTARR

Precision X-Ray

Aug 17, 2023

Register for an engaging webinar led by Naz Chaudary, Ph.D., and Research Technician, Alex Wang from the...

Show all topics (10)

Optical advances – the latest developments in Preclinical imaging

Aug 5, 2016

Preclinical in vivo molecular imaging is widely regarded as a key tool within the drug discovery and development pipeline, giving researchers clear visibility of cellular changes at a molecular level. Techniques – or modalities – such as optical, PET and SPECT imaging provide high specificity and wide applicability, as well as the ability to monitor several molecular events and identify key molecular markers. The result is a deeper understanding of disease progression, and the mode of action and pharmacokinetics of potential therapeutics.

If we consider small animal optical imaging systems specifically, these now enable researchers to combine a number of imaging modalities using the same instrument, thereby paving the way for a better understanding of physiological and disease mechanisms in the preclinical setting. For example, one such system provides five imaging modalities as standard, allowing for co-registration of molecular events with access to bioluminescence, multispectral VIS-NIR fluorescence, unique direct radioisotopic imaging, and Cerenkov radiation. A high speed digital X-ray scanner adds to the functional images with morphological features.

Read more

Scientific paper

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey